Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Treasury Shares (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Treasury Shares for 3 consecutive years, with $1.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Treasury Shares rose 387.04% to $1.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.5 million, a 387.04% increase, with the full-year FY2024 number at $1.5 million, up 387.04% from a year prior.
  • Treasury Shares was $1.5 million for Q4 2024 at Centessa Pharmaceuticals, up from $253518.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.5 million in Q2 2023 to a low of $253518.0 in Q1 2024.
  • A 3-year average of $1.3 million and a median of $1.2 million in 2022 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: tumbled 82.82% in 2023, then soared 387.04% in 2024.
  • Centessa Pharmaceuticals' Treasury Shares stood at $1.8 million in 2022, then crashed by 82.82% to $310052.0 in 2023, then skyrocketed by 387.04% to $1.5 million in 2024.
  • Per Business Quant, the three most recent readings for CNTA's Treasury Shares are $1.5 million (Q4 2024), $253518.0 (Q1 2024), and $310052.0 (Q4 2023).